
A pharmacogenomics test that determines responses to neurological drug therapy based on an individual’s genetic makeup. Genetics can affect drug absorption, metabolism, or activity. Therefore, while one treatment regimen may work well for one individual, the same regimen may cause adverse effects for other individuals.